Literature DB >> 22750050

AMPK signalling and the control of substrate use in the heart.

Jeevan Nagendran1, Terri J Waller, Jason R B Dyck.   

Abstract

All mammalian cells rely on adenosine triphosphate (ATP) to maintain function and for survival. The heart has the highest basal ATP demand of any organ due to the necessity for continuous contraction. As such, the ability of the cardiomyocyte to monitor cellular energy status and adapt the supply of substrates to match the energy demand is crucial. One important serine/threonine protein kinase that monitors cellular energy status in the heart is adenosine monophosphate activated protein kinase (AMPK). AMPK is also a key enzyme that controls multiple catabolic and anabolic biochemical pathways in the heart and indirectly plays a crucial role in regulating cardiac function in both physiological and pathophysiological conditions. Herein, we review the involvement of AMPK in myocardial fatty acid and glucose transport and utilization, as it relates to basal cardiac function. We also assess the literature amassed on cardiac AMPK and discuss the controversies surrounding the role of AMPK in physiological and pathophysiological processes in the heart. The work reviewed herein also emphasizes areas that require further investigation for the purpose of eventually translating this information into improved patient care.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750050     DOI: 10.1016/j.mce.2012.06.015

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

Review 1.  Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.

Authors:  David Roul; Fabio A Recchia
Journal:  Antioxid Redox Signal       Date:  2015-04-30       Impact factor: 8.401

2.  Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.

Authors:  Saifudeen Ismael; Sreeja Purushothaman; V S Harikrishnan; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2015-05-15       Impact factor: 3.396

3.  Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.

Authors:  Nikole J Byrne; Jody Levasseur; Miranda M Sung; Grant Masson; Jamie Boisvenue; Martin E Young; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2016-03-10       Impact factor: 10.787

4.  AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism.

Authors:  Miranda M Sung; Beshay N Zordoky; Adam L Bujak; James S V Lally; David Fung; Martin E Young; Sandrine Horman; Edward J Miller; Peter E Light; Bruce E Kemp; Gregory R Steinberg; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2015-05-28       Impact factor: 10.787

5.  Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I.

Authors:  Andrew N Carley; Domenico M Taglieri; Jian Bi; R John Solaro; E Douglas Lewandowski
Journal:  Circ Heart Fail       Date:  2014-11-25       Impact factor: 8.790

Review 6.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 7.  Regulation of ion channels and transporters by AMP-activated kinase (AMPK).

Authors:  Florian Lang; Michael Föller
Journal:  Channels (Austin)       Date:  2013-12-23       Impact factor: 2.581

8.  Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction.

Authors:  Jingying Wang; Chao Tong; Xiaoyan Yan; Eddie Yeung; Sunilkumar Gandavadi; Alissa A Hare; Xin Du; Yibang Chen; Huabao Xiong; Changxing Ma; Lin Leng; Lawrence H Young; William L Jorgensen; Ji Li; Richard Bucala
Journal:  Circulation       Date:  2013-06-10       Impact factor: 29.690

9.  Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.

Authors:  Wenzheng Xia; Fengyun Zhang; Congying Xie; Miaomiao Jiang; Meng Hou
Journal:  Stem Cell Res Ther       Date:  2015-04-22       Impact factor: 6.832

10.  Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A protein.

Authors:  Jennifer Law; Mohamed Salla; Alaa Zare; Yoke Wong; Le Luong; Natalia Volodko; Orysya Svystun; Kayla Flood; Jonathan Lim; Miranda Sung; Jason R B Dyck; Chong Teik Tan; Yu-Chin Su; Victor C Yu; John Mackey; Shairaz Baksh
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.